项目标题

Size: px

Start display at page:

Download "项目标题"

式山裘
5 years ago
Views:

1 远程医疗和 WebRTC 技术翟磊研发经理英特尔 Web 技术和优化中心

2 议程远程医疗简介及其关键技术 WebRTC 技术及其在远程医疗中的作用面向 WebRTC 的英特尔协同通信开发套件案例分享 : 英特尔助力东软熙康医疗云视频总结

3 议程远程医疗简介及其关键技术 WebRTC 技术及其在远程医疗中的作用面向 WebRTC 的英特尔协同通信开发套件案例分享 : 英特尔助力东软熙康医疗云视频总结

4 什么是远程医疗指远距离提供卫生保健服务具体为医护专业工作者通过使用信息和通信技术交换有效信息进行疾病和损伤的诊断治疗和预防研究和评估, 以及为卫生保健服务提供者继续教育, 所有一切以推动个人及其社区的健康为目标 --- 世界卫生组织指一方医疗机构 ( 邀请方 ) 邀请其他医疗机构 ( 受邀方 ), 运用通讯计算机及网络技术, 为本医疗机构诊疗患者提供技术支持的医疗活动同时, 医疗机构运用信息化技术, 向医疗机构外的患者直接提供的诊疗服务, 也属于远程医疗服务远程医疗服务项目包括 : 远程病理诊断远程医学影像诊断远程监护远程会诊远程门诊远程病例讨论及省级以上卫生部门规定的其他项目 --- 中国卫计委实时通信功能对增强远程医疗用户体验起到至关重要的作用

5 远程医疗实时通信平台建设现状未来建设重点应从大型高端专用化向小型移动通用化转变 ( 图片来自 : 南京鼓楼医院网站 )

6 建立远程医疗通用实时通信平台通用实时通信平台应具备的主要特性同时支持音频视频和数据传输基于 Internet 的高质量音视频体验支持广泛的移动智能终端高安全性与业务逻辑系统高度集成低成本部署

7 议程远程医疗简介及其关键技术 WebRTC 技术及其在远程医疗中的作用面向 WebRTC 的英特尔协同通信开发套件案例分享 : 英特尔助力东软熙康医疗云视频总结

8 WebRTC Web 实时通信 DATA AUDIO VIDEO ORTC 一组 API 定义, 支持浏览器间实时音视频通信同时支持实时音视频传输和数据通道主流浏览器原生支持, 无需安装插件既是 W3C 和 IETF 标准, 又是免费开源项目广泛的设备支持, 预计到 2019 年超过 60 亿台业界领先的基于 Internet 的音视频引擎 API 级支持, 轻松集成现有系统, 比如医疗 HIS 高安全性, 强制 SRTP 加密传输, 轻松 HIPAA 合规良好的防火墙穿透功能, 高连通性业界众多部署, 如 Google Hangout, Facebook Messenger, AT&T WebRTC SDK, 等等 WebRTC 技术特点和建设远程医疗通用实时通信平台的需求高度契合

9 WebRTC 技术应用于远程医疗远程医疗对 WebRTC 技术的扩展要求传统 IE 浏览器对 WebRTC 的支持移动平台 (Android,iOS) 原生 SDK 支持更多医疗智能终端的支持多人音视频通信扩展会话过程录制

10 议程远程医疗简介及其关键技术 WebRTC 技术及其在远程医疗中的作用面向 WebRTC 的英特尔协同通信开发套件案例分享 : 英特尔助力东软熙康医疗云视频总结

11 面向 WebRTC 的英特尔协同通信开发套件端到端的实时音视频解决方案完善且易用的客户端 SDK, Javascript, IE 浏览器插件,Android, ios, C++ for Windows,C++ for Linux ( 开发中 ) 轻松支持多人视频会话和直播模式视频会话兼容不同能力的终端设备灵活的会话录制功能支持 RTSP 外部媒体流接入支持集群式部署, 系统容量轻松扩展基于英特尔核心显卡的高效媒体处理免费获取! 方便部署! 论坛支持!

12 英特尔平台提供极致视觉体验 Intel HD Graphics Power Great Visuals Intel Iris Graphics Experience Life in Ultra HD Intel Iris Pro Graphics Power the Best Processor Graphics

Intel VCA - 英特尔视觉计算加速器 For Emerging 4K, H.265 UHD Transcode / Video Delivery Market Enables 4K HEVC Transcode 3 x Intel Xeon E3 processors with Iris Pro Graphics 12x 2.9GHz Broadwell Cores with AVX2.

1 on Host and VCA; Xen and KVM supported Virtual Ethernet provides connectivity between card and host Brings Media Processing to existing Xeon E5 infrastructure Combines Xeon E3 graphics capabilities

integrated CPU & GPU for excellent quality/ performance * Projected H.264 Transcode 1080p 30fps *54x RT H.265 Transcode 1080p 30fps *6x RT H.

13 Intel VCA - 英特尔视觉计算加速器 For Emerging 4K, H.265 UHD Transcode / Video Delivery Market Enables 4K HEVC Transcode 3 x Intel Xeon E3 processors with Iris Pro Graphics 12x 2.9GHz Broadwell Cores with AVX2.0 Up to 96GB of DDR3 memory Full Length, Full Height, Double-width Gen3 PCIe x16 Card Cent OS 7.1 on Host and VCA; Xen and KVM supported Virtual Ethernet provides connectivity between card and host Brings Media Processing to existing Xeon E5 infrastructure Combines Xeon E3 graphics capabilities with Xeon E5 Compute Power Outstanding TCO (Price/Performance/Power) per Channel Delivers Real time HEVC transcoding: low Storage and Network cost Flexible software architecture Full access to integrated CPU & GPU for excellent quality/ performance * Projected H.264 Transcode 1080p 30fps *54x RT H.265 Transcode 1080p 30fps *6x RT H.265 Transcode 4K 30fps *1x RT Intel's compilers may or may not optimize to the same degree for non-intel microprocessors for optimizations that are not unique to Intel microprocessors. These optimizations include SSE2, SSE3, and SSE3 instruction sets and other optimizations. Intel does not guarantee the availability, functionality, or effectiveness of any optimization on microprocessors not manufactured by Intel. Microprocessor-dependent optimizations in this product are intended for use with Intel microprocessors. Certain optimizations not specific to Intel microarchitecture are reserved for Intel microprocessors. Please refer to the applicable product User and Reference Guides for more information regarding the specific instruction sets covered by this notice. Notice revision # Media Server Studio:

14 议程远程医疗简介及其关键技术 WebRTC 技术及其在远程医疗中的作用面向 WebRTC 的英特尔协同通信开发套件案例分享 : 英特尔助力东软熙康医疗云视频总结

15 熙康云视频服务于熙康云医院熙康云医院远程视频会诊医患视频沟通 * 此页内容由东软熙康提供视频协同医疗

16 熙康云视频服务于家庭 - 医健保姆医健保姆是由东软熙康提供的, 通过互联网 + 医疗的服务模式, 以智能终端为载体, 由家庭医生为用户提供专业的面对面的家庭医疗健康管理服务, 以及家人间的亲情互动 * 此页内容由东软熙康提供

17 议程远程医疗简介及其关键技术 WebRTC 技术及其在远程医疗中的作用面向 WebRTC 的英特尔协同通信开发套件案例分享 : 英特尔助力东软熙康医疗云视频总结

18 总结随着互联网技术的不断发展以及相关政策的不断完善, 远程医疗必将深入改变人们的医疗保健方式, 助其提升效率和质量 WebRTC 技术不断进步为远程医疗提供强有力的后台支撑英特尔公司将继续深耕 WebRTC 领域, 为远程医疗提供高质量的实时通信体验

19 Thank you!

20 Legal Notices and Disclaimers Intel technologies features and benefits depend on system configuration and may require enabled hardware, software or service activation. Learn more at intel.com, or from the OEM or retailer. No computer system can be absolutely secure. Tests document performance of components on a particular test, in specific systems. Differences in hardware, software, or configuration will affect actual performance. Consult other sources of information to evaluate performance as you consider your purchase. For more complete information about performance and benchmark results, visit Cost reduction scenarios described are intended as examples of how a given Intel-based product, in the specified circumstances and configurations, may affect future costs and provide cost savings. Circumstances will vary. Intel does not guarantee any costs or cost reduction. This document contains information on products, services and/or processes in development. All information provided here is subject to change without notice. Contact your Intel representative to obtain the latest forecast, schedule, specifications and roadmaps. Statements in this document that refer to Intel s plans and expectations for the quarter, the year, and the future, are forward-looking statements that involve a number of risks and uncertainties. A detailed discussion of the factors that could affect Intel s results and plans is included in Intel s SEC filings, including the annual report on Form 10-K. The products described may contain design defects or errors known as errata which may cause the product to deviate from published specifications. Current characterized errata are available on request. No license (express or implied, by estoppel or otherwise) to any intellectual property rights is granted by this document. Intel does not control or audit third-party benchmark data or the web sites referenced in this document. You should visit the referenced web site and confirm whether referenced data are accurate. Intel, the Intel logo, Experience What s Inside, Inside, Iris, Atom, Core and Xeon are trademarks of Intel Corporation in the United States and other countries. *Other names and brands may be claimed as the property of others Intel Corporation.

21 Risk Factors The above statements and any others in this document that refer to plans and expectations for the first quarter, the year and the future are forward-looking statements that involve a number of risks and uncertainties. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," "should" and their variations identify forward-looking statements. Statements that refer to or are based on projections, uncertain events or assumptions also identify forward-looking statements. Many factors could affect Intel's actual results, and variances from Intel's current expectations regarding such factors could cause actual results to differ materially from those expressed in these forward-looking statements. Intel presently considers the following to be important factors that could cause actual results to differ materially from the company's expectations. Demand for Intel s products is highly variable and could differ from expectations due to factors including changes in the business and economic conditions; consumer confidence or income levels; customer acceptance of Intel s and competitors products; competitive and pricing pressures, including actions taken by competitors; supply constraints and other disruptions affecting customers; changes in customer order patterns including order cancellations; and changes in the level of inventory at customers. Intel s gross margin percentage could vary significantly from expectations based on capacity utilization; variations in inventory valuation, including variations related to the timing of qualifying products for sale; changes in revenue levels; segment product mix; the timing and execution of the manufacturing ramp and associated costs; excess or obsolete inventory; changes in unit costs; defects or disruptions in the supply of materials or resources; and product manufacturing quality/yields. Variations in gross margin may also be caused by the timing of Intel product introductions and related expenses, including marketing expenses, and Intel s ability to respond quickly to technological developments and to introduce new features into existing products, which may result in restructuring and asset impairment charges. Intel's results could be affected by adverse economic, social, political and physical/infrastructure conditions in countries where Intel, its customers or its suppliers operate, including military conflict and other security risks, natural disasters, infrastructure disruptions, health concerns and fluctuations in currency exchange rates. Results may also be affected by the formal or informal imposition by countries of new or revised export and/or import and doing-business regulations, which could be changed without prior notice. Intel operates in highly competitive industries and its operations have high costs that are either fixed or difficult to reduce in the short term. The amount, timing and execution of Intel s stock repurchase program and dividend program could be affected by changes in Intel s priorities for the use of cash, such as operational spending, capital spending, acquisitions, and as a result of changes to Intel s cash flows and changes in tax laws. Product defects or errata (deviations from published specifications) may adversely impact our expenses, revenues and reputation. Intel s results could be affected by litigation or regulatory matters involving intellectual property, stockholder, consumer, antitrust, disclosure and other issues. An unfavorable ruling could include monetary damages or an injunction prohibiting Intel from manufacturing or selling one or more products, precluding particular business practices, impacting Intel s ability to design its products, or requiring other remedies such as compulsory licensing of intellectual property. Intel s results may be affected by the timing of closing of acquisitions, divestitures and other significant transactions. A detailed discussion of these and other factors that could affect Intel s results is included in Intel s SEC filings, including the company s most recent reports on Form 10-Q, Form 10-K and earnings release. Rev. 1/15/15

untitled

untitled Safe Harbor This presentation contains statements of a forward-looking nature. These statements are made under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. You